Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2014
10/02/2014WO2014154173A1 Anti-angiogenic compound
10/02/2014WO2014154168A1 Bicyclic substituted pyrimidine pde-5 inhibitor prodrug
10/02/2014WO2014153624A1 Antibacterial compounds
10/02/2014US20140296532 Compositions and methods for the treatment of malaria
10/02/2014US20140296514 Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
10/02/2014US20140296292 Methods and compositions associated with the granulocyte colony-stimulating factor receptor
10/02/2014US20140296268 Therapeutic methods and compositions involving allosteric kinase inhibition
10/02/2014US20140296238 Dihydropyrazoles
10/02/2014US20140296225 Inhibitors of the Renal Outer Medullary Potassium Channel
10/02/2014US20140296217 Medicaments for the treatment or prevention of fibrotic diseases
10/02/2014US20140296213 New polymorph
10/02/2014US20140296212 Substituted phenoxypropylcycloamine derivatives as histamine-3 (h3) receptor ligands
10/02/2014US20140296206 Compositions useful for treating disorders related to kit
10/02/2014US20140294962 Method of preparing polymorphic pure form a of bazedoxifene acetate
10/02/2014US20140294808 Treating cancer with hsp90 inhibitory compounds
10/02/2014US20140294767 Method of treating hcv infection with a small molecule chk2 inhibitor
10/01/2014EP2784076A1 Dimeric SMAC mimetics
10/01/2014EP2784075A1 Hepatitis C virus inhibitors
10/01/2014EP2784074A1 Pyrazole compound and use thereof for medical purposes
10/01/2014EP2784073A1 3-phenyl-4-pyri(mi)dinyl-1h-pyrazoles and their use as fungicides
10/01/2014EP2784072A1 3-phenyl-4-pyri(mi)dinyl-1h-pyrazoles and their use as fungicides
10/01/2014EP2784071A1 3-phenyl-4-pyri(mi)dinyl-1h-pyrazoles and their use as fungicides
10/01/2014EP2784070A1 3-phenyl-4-pyri(mi)dinyl-1h-pyrazoles and their use as fungicides
10/01/2014EP2782903A1 Novel pyrrolidine derivatives as inhibitors of cathepsin
09/2014
09/30/2014US8846953 Processes for the preparation of 3-(pyrrol-2-yl)methylene)-2-pyrrolones using 2-silyloxy-pyrroles
09/30/2014US8846950 Trianionic pincer ligands, a CR(III)/CR(V) catalytic system and its use for catalytic aerobic oxidation of organic substrates
09/30/2014US8846948 Compounds
09/30/2014US8846947 Benzimidazoles and related analogs as sirtuin modulators
09/30/2014US8846933 N-link hydroxamic acid derivatives useful as antibacterial agents
09/30/2014US8846917 Compounds useful as inhibitors of ATR kinase
09/30/2014US8846913 Neprilysin inhibitors
09/30/2014US8846912 Tartrate salts of quinazoline based EGFR inhibitors containing a zinc binding moiety
09/30/2014US8846910 Matrix metalloproteinase inhibitors
09/30/2014US8846906 5HT2C receptor modulators
09/30/2014US8846746 Pyrazole compound and pharmaceutical use thereof
09/30/2014US8846743 Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
09/30/2014US8846741 N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
09/30/2014US8846739 TGR5 agonists
09/30/2014US8846736 Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
09/30/2014US8846727 Haloalkyl heteroaryl benzamide compounds
09/30/2014US8846705 Diaminopyrimidines as P2X3 and P2X2/3 antagonists
09/30/2014US8846694 Pyrrolidone derivatives for use as MetAP-2 inhibitors
09/30/2014US8846682 Compound suitable for the treatment of synucleopathies
09/30/2014US8846681 Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
09/30/2014US8846660 Seven-membered ring compound and pharmaceutical use therefor
09/30/2014US8846654 Therapeutic applications in the cardiovascular field of quinazolinedione derivatives
09/30/2014US8846411 Derivatives, reagents, and immunoassay for detecting levetiracetam
09/30/2014US8846215 Organic light-emitting diode and method for manufacturing same
09/30/2014US8846023 Hepatitis C virus inhibitors
09/25/2014WO2014153226A1 Arginine methyltransferase inhibitors and uses thereof
09/25/2014WO2014153214A1 Arginine methyl transferase inhibtors and uses thereof
09/25/2014WO2014152588A1 Covalent inhibitors of kras g12c
09/25/2014WO2014151936A1 Octahydropyrrolopyrroles, their preparation and use
09/25/2014WO2014151761A1 Novel choline kinase inhibitors
09/25/2014WO2014151682A1 Pyrimidine compounds as kinase inhibitors
09/25/2014WO2014151616A1 Biaryl amide compounds as kinase inhibitors
09/25/2014WO2014151380A1 1,2,6-substituted benzimidazoles as flap modulators
09/25/2014WO2014151106A1 Histone demethylase inhibitors
09/25/2014WO2014150261A1 Compounds and uses thereof for the modulaton of hemoglobin
09/25/2014WO2014149171A1 Total synthesis of thaxtomin a analogues and their intermediates
09/25/2014WO2014148493A1 Light-emitting device
09/25/2014WO2014147586A1 1-(2-(ethylamino)pyrimidin-4-yl)pyrrolidin-2-ones as inhibitors of mutant idh
09/25/2014WO2014147203A1 3-heteroaryl substituted indazoles
09/25/2014WO2014147144A1 Diaminoheteroaryl substituted indazoles
09/25/2014WO2014147078A1 New family of discriminating molecules for neutron and gamma rays and ionic liquids
09/25/2014WO2014146752A1 Materials for electronic devices
09/25/2014US20140288301 Triazole compounds that modulate hsp90 activity
09/25/2014US20140288124 Arginine methyltransferase inhibitors and uses thereof
09/25/2014US20140288105 Arginine methyltransferase inhibitors and uses thereof
09/25/2014US20140288100 Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders
09/25/2014US20140288091 Mono-fluoro beta-secretase inhibitors
09/25/2014US20140288090 N-arylylmethylindazole modulators of pparg
09/25/2014US20140288086 Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
09/25/2014US20140288084 Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m1
09/25/2014US20140288067 Carm1 inhibitors and uses thereof
09/25/2014US20140288065 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
09/25/2014US20140288063 Heterocyclic Substituted Pyrimidine Compound
09/25/2014US20140288050 Modulators of opioid receptors and methods of use thereof
09/25/2014US20140288049 2-Thiopyrimidinones
09/25/2014US20140288048 Heterocyclic compounds and uses thereof
09/24/2014EP2781508A1 Nitrogen-containing fused ring compounds for use as crth2 antagonists
09/24/2014EP2780342A1 Aminoquinazoline derivatives and their salts and methods of use
09/24/2014EP2780331A1 Pharmaceutically active pyrazine derivatives
09/24/2014EP2780322A1 Methods and compositions associated with the granulocyte colony-stimulating factor receptor
09/24/2014EP2780321A1 Mono-fluoro beta-secretase inhibitors
09/23/2014US8841447 Process for the preparation of alogliptin
09/23/2014US8841337 Compounds useful as inhibitors of ATR kinase
09/23/2014US8841324 Heterocyclic compounds as autotaxin inhibitors
09/23/2014US8841312 Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors
09/23/2014US8841309 Substituted pyrazines and their use in the treatment of disease
09/23/2014US8841305 Activators of the human pyruvate kinase M2 receptor
09/23/2014US8841301 Selective NR2B antagonists
09/23/2014US8841295 5-lipoxygenase-activating protein (FLAP) inhibitors
09/23/2014US8841288 Quinolin-4 (1H)-one derivatives as inhibitors of phosphatidylinositol 3-kinases
09/23/2014US8841278 Antiviral compounds
09/23/2014US8840878 Peptidomimetic sulfamide compounds and antiviral uses thereof
09/23/2014US8840865 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
09/23/2014CA2752527C Indole/benzimidazole compounds as mtor kinase inhibitors
09/23/2014CA2582347C Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
09/23/2014CA2575853C Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 ... 626